Medikine, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors (NCT05716295) | Medikine, Inc. | 2023-02-08 |
| A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers (NCT05366634) | Medikine, Inc. | 2022-06-30 |
Track Medikine, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.